AT MARKET ISSUANCE SALES AGREEMENTAt Market Issuance Sales Agreement • December 30th, 2016 • Novavax Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 30th, 2016 Company Industry JurisdictionNovavax, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co., a Delaware limited liability company (“FBR”), as follows: